Merck rises after third guidance upgrade this year

By Reuters News

** Shares in Merck KGaA MRCG.DE are up around 2% after the German science and technology group raised its 2026 guidance for the third time this year

** Merck now expects EBITDA pre of €6.2 billion-€6.4 billion this year, up from €5.9 billion-€6.3 billion previously, and revenue in €21.5 billion-€21.9 billion range versus €21.0 billion-€21.8 billion previously

** Jefferies notes that both Q3 sales and adjusted EBITDA beat expectations by 3% and 5%, respectively, driven by strong performances in Life Science and Electronics

** The broker says Semi Materials delivered "another record quarter", helping Semiconductor Solutions sales grow 18.7%, well ahead of 9.9% consensus



($1 = 0.9027 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.